MedTrace Logo

SNAP: Study Nutrients in Adult PKU

NCT03858101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2023-06-02

No results posted yet for this study

Summary

Phenylketonuria (PKU) is a rare inherited metabolic disorder, where subjects are born with a genetic deficiency in the phenylalanine hydroxylase enzyme (PAH), which leaves them unable to convert Phenylalanine (Phe) into Tyrosine (Tyr). PKU patients have specific dietary needs and must follow a restrictive diet in the aim of preventing toxic levels of the amino acid phenylalanine (Phe) accumulation.

Conditions

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2023-03-03
Completion
2023-05-15

Countries

  • Belgium
  • Denmark
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858101 on ClinicalTrials.gov